Israel Englander Ambrx Biopharma Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.66 - $16.46 $2.1 Million - $4.52 Million	274,727 Added 2500.02%	285,716 $4.7 Million
Q1 2023 May 15, 2023	SELL	$1.46 - $12.54 $11,393 - $97,862	-7,804 Reduced 41.53%	10,989 $98,000
Q4 2022 Feb 14, 2023	SELL	$0.41 - $4.54 $38,908 - $430,841	-94,899 Reduced 83.47%	18,793 $43,000
Q3 2022 Nov 14, 2022	BUY	$1.06 - $2.96 $11,570 - $32,311	10,916 Added 10.62%	113,692 $123,000

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.